Literature DB >> 31466685

Pediatric Inner-City Asthma.

Divya Seth1, Shweta Saini2, Pavadee Poowuttikul3.   

Abstract

Inner-city children with asthma are known to have high disease mortality and morbidity. Frequently, asthma in this high-risk population is difficult to control and more severe in nature. Several factors, including socioeconomic hardship, ability to access to health care, adherence to medication, exposure to certain allergens, pollution, crowd environment, stress, and infections, play an important role in the pathophysiology of inner-city asthma. Comprehensive control of home allergens and exposure to tobacco smoke, the use of immune based therapies, and school-based asthma programs have shown promising results in asthma control in this population.
Copyright © 2019 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Asthma; Asthma research networks; Children; Inner city

Mesh:

Substances:

Year:  2019        PMID: 31466685     DOI: 10.1016/j.pcl.2019.06.012

Source DB:  PubMed          Journal:  Pediatr Clin North Am        ISSN: 0031-3955            Impact factor:   3.278


  3 in total

1.  Long-term effects of a peer-led asthma self-management program on asthma outcomes in adolescent peer leaders.

Authors:  Hyekyun Rhee; Tanzy Love; Donald Harrington; Leanne Walters; Jennifer Mammen; Elizabeth Sloand
Journal:  Patient Educ Couns       Date:  2020-12-03

2.  Long-term Effectiveness of a Peer-Led Asthma Self-management Program on Asthma Outcomes in Adolescents Living in Urban Areas: A Randomized Clinical Trial.

Authors:  Hyekyun Rhee; Tanzy Love; Mona N Wicks; Laurene Tumiel-Berhalter; Elizabeth Sloand; Donald Harrington; Leanne Walters
Journal:  JAMA Netw Open       Date:  2021-12-01

Review 3.  Toward personalization of asthma treatment according to trigger factors.

Authors:  Katarzyna Niespodziana; Kristina Borochova; Petra Pazderova; Thomas Schlederer; Natalia Astafyeva; Tatiana Baranovskaya; Mohamed-Ridha Barbouche; Evgeny Beltyukov; Angelika Berger; Elena Borzova; Jean Bousquet; Roxana S Bumbacea; Snezhana Bychkovskaya; Luis Caraballo; Kian Fan Chung; Adnan Custovic; Guillermo Docena; Thomas Eiwegger; Irina Evsegneeva; Alexander Emelyanov; Peter Errhalt; Rustem Fassakhov; Rezeda Fayzullina; Elena Fedenko; Daria Fomina; Zhongshan Gao; Pedro Giavina-Bianchi; Maia Gotua; Susanne Greber-Platzer; Gunilla Hedlin; Natalia Ilina; Zhanat Ispayeva; Marco Idzko; Sebastian L Johnston; Ömer Kalayci; Alexander Karaulov; Antonina Karsonova; Musa Khaitov; Elena Kovzel; Marek L Kowalski; Dmitry Kudlay; Michael Levin; Svetlana Makarova; Paolo Maria Matricardi; Kari C Nadeau; Leyla Namazova-Baranova; Olga Naumova; Oleksandr Nazarenko; Paul M O'Byrne; Faith Osier; Alexander N Pampura; Carmen Panaitescu; Nikolaos G Papadopoulos; Hae-Sim Park; Ruby Pawankar; Wolfgang Pohl; Harald Renz; Ksenja Riabova; Vanitha Sampath; Bülent E Sekerel; Elopy Sibanda; Valérie Siroux; Ludmila P Sizyakina; Jin-Lyu Sun; Zsolt Szepfalusi; Tetiana Umanets; Hugo P S Van Bever; Marianne van Hage; Margarita Vasileva; Erika von Mutius; Jiu-Yao Wang; Gary W K Wong; Sergii Zaikov; Mihaela Zidarn; Rudolf Valenta
Journal:  J Allergy Clin Immunol       Date:  2020-02-18       Impact factor: 14.290

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.